High Content Screening Market by Product (Accessories, Consumables, Instruments), Application (Explorative Screening, Neurobiology, Oncology), End User - Global Forecast 2024-2030


Attention: There is an updated edition available for this report.

High Content Screening Market by Product (Accessories, Consumables, Instruments), Application (Explorative Screening, Neurobiology, Oncology), End User - Global Forecast 2024-2030


The High Content Screening Market size was estimated at USD 840.72 million in 2023 and expected to reach USD 926.25 million in 2024, at a CAGR 10.26% to reach USD 1,666.38 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the High Content Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the High Content Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the High Content Screening Market, highlighting leading vendors and their innovative profiles. These include Advanced Solutions, Inc., Agilent Technologies, Inc., Aurora Biomed Inc., Axxam S.p.A, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Danaher Corporation, Genedata AG, Merck KGaA, Ncardia Services BV, Perkinelmer, Inc., Sartorius AG, SPT Labtech Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage



This research report categorizes the High Content Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Accessories
Consumables
Microplates

Reagents & Assay Kits
Instruments
Cell Imaging & Analysis Systems

Flow Cytometers
Services
Software
Application
Explorative Screening
Neurobiology
Oncology
Target Validation
Toxicology
End User
Biotechnology
Educational Institutions
Government Organizations
Independent CRO
Pharmaceutical & Healthcare
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the High Content Screening Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the High Content Screening Market?
3. What are the technology trends and regulatory frameworks in the High Content Screening Market?
4. What is the market share of the leading vendors in the High Content Screening Market?
5. Which modes and strategic moves are suitable for entering the High Content Screening Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. High Content Screening Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing application of high-content screening in life science research
5.1.1.2. Advancements in the imaging solutions
5.1.1.3. Favorable government regulations and investment in the developed countries
5.1.2. Restraints
5.1.2.1. Higher cost of high content screening
5.1.3. Opportunities
5.1.3.1. Technological advancement in the high throughput screening for drug discovery
5.1.3.2. Amalgamation of high throughput 3D cell-based models with advances in material sciences
5.1.4. Challenges
5.1.4.1. Lack of healthcare infrastructure and investments for HCS in emerging economies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. High Content Screening Market, by Product
6.1. Introduction
6.2. Accessories
6.3. Consumables
6.4.1. Microplates
6.4.2. Reagents & Assay Kits
6.4. Instruments
6.5.1. Cell Imaging & Analysis Systems
6.5.2. Flow Cytometers
6.5. Services
6.6. Software
7. High Content Screening Market, by Application
7.1. Introduction
7.2. Explorative Screening
7.3. Neurobiology
7.4. Oncology
7.5. Target Validation
7.6. Toxicology
8. High Content Screening Market, by End User
8.1. Introduction
8.2. Biotechnology
8.3. Educational Institutions
8.4. Government Organizations
8.5. Independent CRO
8.6. Pharmaceutical & Healthcare
9. Americas High Content Screening Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific High Content Screening Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa High Content Screening Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Advanced Solutions, Inc.
13.1.2. Agilent Technologies, Inc.
13.1.3. Aurora Biomed Inc.
13.1.4. Axxam S.p.A
13.1.5. Becton, Dickinson and Company
13.1.6. Bio-Rad Laboratories, Inc.
13.1.7. Cell Signaling Technology, Inc.
13.1.8. Danaher Corporation
13.1.9. Genedata AG
13.1.10. Merck KGaA
13.1.11. Ncardia Services BV
13.1.12. Perkinelmer, Inc.
13.1.13. Sartorius AG
13.1.14. SPT Labtech Ltd.
13.1.15. Tecan Trading AG
13.1.16. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. HIGH CONTENT SCREENING MARKET RESEARCH PROCESS
FIGURE 2. HIGH CONTENT SCREENING MARKET SIZE, 2023 VS 2030
FIGURE 3. HIGH CONTENT SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HIGH CONTENT SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HIGH CONTENT SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HIGH CONTENT SCREENING MARKET DYNAMICS
FIGURE 7. HIGH CONTENT SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. HIGH CONTENT SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HIGH CONTENT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. HIGH CONTENT SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HIGH CONTENT SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. HIGH CONTENT SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HIGH CONTENT SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HIGH CONTENT SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HIGH CONTENT SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HIGH CONTENT SCREENING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HIGH CONTENT SCREENING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings